A detailed history of Cladis Investment Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Cladis Investment Advisory, LLC holds 51,910 shares of PFE stock, worth $1.52 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares
51,910
Previous 50,608 2.57%
Holding current value
$1.52 Million
Previous $1.4 Million 3.42%
% of portfolio
1.27%
Previous 1.24%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$25.26 - $29.6 $32,888 - $38,539
1,302 Added 2.57%
51,910 $1.45 Million
Q1 2024

May 13, 2024

BUY
$25.89 - $29.73 $199,430 - $229,010
7,703 Added 17.95%
50,608 $1.4 Million
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $167,022 - $216,944
6,392 Added 17.51%
42,905 $1.24 Million
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $8,792 - $10,277
-274 Reduced 0.74%
36,513 $1.21 Million
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $18,710 - $21,647
-518 Reduced 1.39%
36,787 $1.35 Million
Q1 2023

May 15, 2023

SELL
$39.39 - $51.28 $3,466 - $4,512
-88 Reduced 0.24%
37,305 $1.52 Million
Q4 2022

Feb 14, 2023

SELL
$41.75 - $54.5 $20,791 - $27,141
-498 Reduced 1.31%
37,393 $1.92 Million
Q3 2022

Nov 17, 2022

SELL
$43.76 - $53.42 $30,194 - $36,859
-690 Reduced 1.79%
37,891 $1.66 Million
Q2 2022

Aug 09, 2022

SELL
$46.53 - $55.17 $111,625 - $132,352
-2,399 Reduced 5.85%
38,581 $2.02 Million
Q1 2022

May 10, 2022

SELL
$45.75 - $56.69 $11,391 - $14,115
-249 Reduced 0.6%
40,980 $2.12 Million
Q4 2021

Oct 01, 2024

SELL
$41.32 - $61.25 $234,738 - $347,961
-5,681 Reduced 10.94%
46,229 $2.43 Billion
Q4 2021

May 10, 2022

BUY
$41.32 - $61.25 $1.7 Million - $2.53 Million
41,229 New
41,229 $2.44 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $164B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Cladis Investment Advisory, LLC Portfolio

Follow Cladis Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cladis Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cladis Investment Advisory, LLC with notifications on news.